KEWALRAMANI RESHMA (CEO & President) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000875320-26-000090
DirectorOfficer· CEO & President
Since Feb 2026
+9.77K
Net shares
Net buyer
$3.17M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
16.33K acquired · 6.55K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.33K
Price / share
—
Trade value
—
% of position
12.2%
2/17/2026
133.49K→149.81K
Common Stock
Direct
Shares
−6.55K
Price / share
$483.75
Trade value
$3.17M
% of position
4.4%
2/17/2026
149.81K→143.26K
Total
Net shares
+9.77K
Net value
-$3.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +16.33K | — | — | 12.2% | 133.49K | 149.81K |
| Common Stock Direct | 2/17/2026 | F · Tax Withholding | −6.55K | $483.75 | $3.17M | 4.4% | 149.81K | 143.26K |
| Total | +9.77K | -$3.17M | ||||||
Derivative Transactions0
No derivative transactions reported